Idioma:

NCYM is upregulated by lncUSMycN and modulates N-Myc expression

Liu, Pei Y ; Atmadibrata, Bernard ; Mondal, Sujanna ; Tee, Andrew E ; Liu, Tao

International journal of oncology, 2016-12, Vol.49 (6), p.2464-2470 [Periódico revisado por pares]

Greece: D.A. Spandidos

Texto completo disponível

Citações Citado por

Enviar para

Título:
NCYM is upregulated by lncUSMycN and modulates N-Myc expression
Autor: Liu, Pei Y ; Atmadibrata, Bernard ; Mondal, Sujanna ; Tee, Andrew E ; Liu, Tao
Assuntos: Apoptosis ; Azepines - pharmacology ; Cancer ; Care and treatment ; Cell growth ; Cell Line, Tumor ; Cell Proliferation - genetics ; Datasets ; Deoxyribonucleic acid ; Development and progression ; DNA ; Gene expression ; Gene Expression Regulation, Neoplastic ; Genetic aspects ; Health aspects ; Heterocyclic Compounds, 4 or More Rings - pharmacology ; Histones - metabolism ; Humans ; Kinases ; lncUSMycN ; Medical prognosis ; Messenger RNA ; Metastasis ; Methylation ; N-Myc ; NCYM ; Neoplasm Proteins - biosynthesis ; Neoplasm Proteins - genetics ; Neuroblastoma ; Neuroblastoma - pathology ; Nuclear Matrix-Associated Proteins - metabolism ; Octamer Transcription Factors - metabolism ; Patients ; Prognosis ; Promoter Regions, Genetic - genetics ; Protein Binding - genetics ; Proteins ; RNA Interference ; RNA, Long Noncoding - genetics ; RNA, Messenger - biosynthesis ; RNA, Small Interfering ; RNA-Binding Proteins - metabolism ; Studies ; Triazoles - pharmacology ; Variance analysis
É parte de: International journal of oncology, 2016-12, Vol.49 (6), p.2464-2470
Descrição: Neuroblastoma is the most common solid tumor in early childhood. Patients with neuroblastoma due to the amplification of a 130-kb genomic DNA region containing the MYCN, MYCN antisense NCYM and lncUSMycN genes show poor prognosis. BET bromodomain inhibitors show anticancer efficacy against neuroblastoma partly by reducing MYCN gene transcription and N-Myc mRNA and protein expression. We have previously shown that the long nocoding RNA lncUS-MycN upregulates N-Myc mRNA expression by binding to the RNA-binding protein NonO. In this study, we found that lncUSMycN upregulated NCYM expression, and knocking-down lncUSMycN reduced histone H3 lysine 4 trimethylation, a marker for active gene transcription, at the NCYM gene promoter. NCYM upregulated N-Myc mRNA expression, NCYM RNA formed a complex with NonO protein, and knocking down NCYM expression reduced neuroblastoma cell proliferation. Importantly, treatment with BET bromodomain inhibitors reduced NCYM expression. In human neuroblastoma patients, high levels of NCYM expression in tumor tissues correlated with high levels of N-Myc, NonO and lncUSMycN expression as well as poor patient prognosis. Taken together, our findings suggest that lncUSMycN upregulates NCYM expression by activating its gene transcription, and that NCYM RNA upregulates N-Myc mRNA expression by binding to NonO. Our findings also provide further evidence for the application of BET bromodomain inhibitors for the therapy of neuroblastoma characterized by MYCN/NCYM gene locus amplification.
Editor: Greece: D.A. Spandidos
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 4 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

NCYM is upregulated by lncUSMycN and modulates N-Myc expression

Liu, Pei Y ; Atmadibrata, Bernard ; Mondal, Sujanna ; Tee, Andrew E ; Liu, Tao

Greece: D.A. Spandidos

Buscando em bases de dados remotas. Favor aguardar.